Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Abbott Laboratories Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $83.4 Billion
- Q1 2025
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Abbott Laboratories stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 4,802,846 shares of ABT stock, worth $653 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
4,802,846
Previous 971,815
394.21%
Holding current value
$653 Million
Previous $110 Million
479.6%
% of portfolio
0.76%
Previous 0.12%
Shares
36 transactions
Others Institutions Holding ABT
# of Institutions
3,546Shares Held
1.38BCall Options Held
9.75MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA170MShares$23.1 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.6 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$9.09 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.9 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $238B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...